Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Christina Hanzis"'
Autor:
Christopher J. Patterson, Megan Lewicki, Leukothea Ioakimidis, Tabatha N. Offutt-Powell, Robert Manning, Sander Greenland, Christina Hanzis, Steven P. Treon, Rohit P. Ojha, Philip Brodsky, Christina K. Tripsas, Zachary R. Hunter, Patricia Sheehy, Karan P. Singh
Publikováno v:
Cancer Epidemiology. 36:294-297
Background Little is known about the epidemiology and etiology of Waldenstrom macroglobulinemia (WM). Despite several studies of the relation between family history and B-cell disorders and WM, family history of non-hematologic cancers has not been s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::000b1b61da9f854a540b7e065e6b52df
https://doi.org/10.1016/j.canep.2011.10.010
https://doi.org/10.1016/j.canep.2011.10.010
Autor:
Leukothea Ioakimidis, Christopher J. Patterson, Robert Manning, Christina Hanzis, Patricia Sheehy, Barry Turnbull, Zachary R. Hunter, Steven P. Treon
Publikováno v:
British Journal of Haematology. 154:357-362
Summary This study examined the outcome of 248 Waldenstrom macroglobulinaemia (WM) rituximab-naive patients who responded to a rituximab-containing regimen. Eighty-six patients (35%) subsequently received maintenance rituximab (M-Rituximab). No diffe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f992f9d34c8cc9f5ce879118c4bef3ea
https://doi.org/10.1111/j.1365-2141.2011.08750.x
https://doi.org/10.1111/j.1365-2141.2011.08750.x
Autor:
Robert Manning, Patricia Sheehy, Christina K. Tripsas, Christopher J. Patterson, Christina Hanzis, Leukothea Ioakimidis, Steven P. Treon
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 11:133-135
We report the treatment outcome for 30 relapsed/refractory Waldenstrom's macroglobulinemia (WM) patients following bendamustine-containing therapy. Treatment consisted of bendamustine (90 mg/m2 I.V. on days 1, 2) and rituximab (375 mg/m2 I.V. on eith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe0d93cc5ccfced73aaa3d9baa7204a
https://doi.org/10.3816/clml.2011.n.030
https://doi.org/10.3816/clml.2011.n.030
Autor:
Steven P. Treon, Christina K. Tripsas, Robert Manning, Zachary R. Hunter, Leukothea Ioakimidis, Patricia Sheehy, Barry Turnbull, Christopher J. Patterson, Christina Hanzis
Publikováno v:
Clinical lymphoma, myelomaleukemia. 12(6)
Familial disease is common in Waldenström macroglobulinemia (WM). We examined the impact of familial disease status on treatment outcome in WM and observed that familial disease was associated with inferior outcomes. However patients with familial W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0ae400e47d81011ade0c917932f8ce1
https://pubmed.ncbi.nlm.nih.gov/23084402
https://pubmed.ncbi.nlm.nih.gov/23084402
Autor:
Steven P, Treon, Christina, Hanzis, Robert J, Manning, Leukothea, Ioakimidis, Christopher J, Patterson, Zachary R, Hunter, Patricia, Sheehy, Barry, Turnbull
Publikováno v:
British journal of haematology. 154(3)
This study examined the outcome of 248 Waldenstrom macroglobulinaemia (WM) rituximab-naïve patients who responded to a rituximab-containing regimen. Eighty-six patients (35%) subsequently received maintenance rituximab (M-Rituximab). No differences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a205867277fefbe3b577d5973e98b624
https://pubmed.ncbi.nlm.nih.gov/21615385
https://pubmed.ncbi.nlm.nih.gov/21615385
Autor:
Bryan Ciccarelli, Hsiuyi Tseng, Yang Cao, Leukothea Ioakimidis, Steven P. Treon, Christopher J. Patterson, Jenny Sun, Xia Liu, Zachary R. Hunter, Patricia Sheehy, Yangsheng Zhou, Scott J. Rodig, Lian Xu, Robert Manning, Guang Yang, Christina Hanzis
Publikováno v:
Clinical lymphoma, myelomaleukemia. 11(1)
Waldenstrom's macroglobulinemia (WM) patients often present with anemia as their primary disease manifestation that may be related to hepcidin, an important regulator of iron homeostasis. We therefore determined hepcidin levels in 53 WM patients, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44f9725897d8dd739a4f219ebe8f44d7
https://pubmed.ncbi.nlm.nih.gov/21454222
https://pubmed.ncbi.nlm.nih.gov/21454222
Autor:
Patricia Sheehy, Steven P. Treon, Christina K. Tripsas, Megan Lewicki, Christopher J. Patterson, Zachary R. Hunter, Rohit P. Ojha, Robert Manning, Leukothea Ioakimidis, Christina Hanzis, Philip Brodsky
Publikováno v:
Clinical lymphoma, myelomaleukemia. 11(1)
We examined the incidence of other malignancies in 924 Waldenstrom's Macroglobulinemia (WM) patients and their kin. A total of 225 (24.3%) patients had ≥1 additional malignancy, with 63% predating the WM diagnosis. The most common gender-adjusted m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe9cc46c7bdca80b0f551c73b0b4e73e
https://pubmed.ncbi.nlm.nih.gov/21454200
https://pubmed.ncbi.nlm.nih.gov/21454200
Autor:
Christopher J. Patterson, Lian Xu, Zachary R. Hunter, Steven P. Treon, Robert Manning, Xia Liu, Jason M. Laramie, Christina Hanzis, Donald A Skifter, Guang Yang, Stephen E Lincoln, Patricia Sheehy, Yangsheng Zhou, Yang Cao
Publikováno v:
Blood. 118:300-300
Abstract 300 We performed whole genome sequencing (WGS) of lymphoplasmacytic cells from 30 Waldenstrom's Macroglobulinemia (WM) patients, with paired normal tissue sequencing for 10 patients. Tumor and normal genomes were both sequenced to an average
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35d5f017ca2a5d8df8ba4255ee7051ea
https://doi.org/10.1182/blood.v118.21.300.300
https://doi.org/10.1182/blood.v118.21.300.300
Autor:
Barry Turnbull, Leukothea Ioakimidis, Steven P. Treon, Christina K. Tripsas, Robert Manning, Zachary R. Hunter, Patricia Sheehy, Christina Hanzis, Christopher J. Patterson
Publikováno v:
Blood. 118:1643-1643
Abstract 1643 We examined the impact of familial predisposition on treatment outcome in 135 Waldenstrom's macroglobulinaemia (WM) patients, 26.7% of whom had first or second degree relative(s) with a B-cell lymphoproliferative disorder. All patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f437e04a7465de365529694a27b71245
https://doi.org/10.1182/blood.v118.21.1643.1643
https://doi.org/10.1182/blood.v118.21.1643.1643
Autor:
Robert Manning, Patricia Sheehy, Xia Liu, Steven P. Treon, Lian Xu, Yangsheng Zhou, Christopher J. Patterson, Jason M. Laramie, Yang Cao, Donald A Skifter, Zachary R. Hunter, Stephen E Lincoln, Guang Yang, Christina Hanzis
Publikováno v:
Blood. 118:434-434
Abstract 434 Introduction: The primary oncogenetic event resulting in malignant transformation in Waldenstrom's Macroglobulinemia (WM) remains to be delineated. We therefore employed whole genome sequencing (WGS) to help identify potential somatic va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f26fde6293dfa46140fc4ea509dd075d
https://doi.org/10.1182/blood.v118.21.434.434
https://doi.org/10.1182/blood.v118.21.434.434